Sharemaestro Newsreel

Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem

Eli Lilly (NYSE: LLY) is already the leader in the weight-loss market thanks to Zepbound, the best-selling medication in this space. However, the drugmaker has been making headlines with its next-gen anti-obesity medicine, retatrutide. Eli Lilly recently announced that it will request approval from …

Edwards Lifesciences Corp (EW) Aktuelle Aktien-News

UnitedHealth Stock Rallies 21% on Raised 2026 Guidance. Here’s What Changed

Intuitive Surgical Inc (ISRG) Aktienanalyse & Prognose

Johnson & Johnson (JNJ) Aktienanalyse & Prognose

Novo Nordisk A/S (NVO) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

Elevance Health Inc (ELV) Aktuelle Aktien-News

Novo Nordisk Stock Rises After GLP-1 Antitrust Win

This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the Danish pharmaceutical giant behind Ozempic and Wegovy, edged nearly 2% higher during Friday's U.S. regular session after a federal judge threw out an antitrust lawsuit against Novo and Eli Lilly (NYSE:LLY). According to Reuters, …

Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound

Key Points Pfizer's berobenatide appears to be a promising candidate that could challenge Wegovy and Zepbound. There are several other reasons to consider the stock, despite the potential headwinds ahead. 10 stocks we like better than Pfizer › The past few years have been …

Roche Stock Jumps as Morgan Stanley Sees Drug Breakout

This article first appeared on GuruFocus. Roche Holding (RHHBY), the Swiss pharmaceutical and diagnostics giant, got a major Wall Street vote of confidence after Morgan Stanley upgraded the stock to Overweight from Equal Weight and hiked its ADR price target to $63 from $46. …

Johnson & Johnson (JNJ) Reaches $5.5 Billion Talc Settlement To Close Years Of Lawsuits

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Johnson & Johnson (NYSE: JNJ) agreed to a US$5.5b settlement to resolve tens of thousands of talc baby powder lawsuits. The deal ends decades of …

What Do Boston Scientific (BSX) Recalls Mean For Device Safety And Clinical Use?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Boston Scientific (NYSE: BSX) has initiated multiple product recalls covering cardiac ablation generators and vascular access sheaths due to labeling discrepancies and air …

Catalyst Watch: Inflation reads, AMAT earnings, Google Pixel event, and MLB on Netflix

[Lower Manhattan Cityscape] Art Wager/E+ via Getty Images Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY - AUGUST 10 * …

Pfizer Inc (PFE) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong

Cytokinetics, Incorporated CYTK reported a second-quarter 2026 loss of $1.50 per share, narrower than the Zacks Consensus Estimate of a loss of $1.63 per share. In the year-ago quarter, the company reported a loss of $1.12 per share. Loss widened year over year due …

NVAX Q2 Earnings & Sales Beat Estimates, '26 Sales Outlook Raised

Novavax NVAX incurred a loss of 32 cents per share in the second quarter of 2026, narrower than the Zacks Consensus Estimate of a loss of 36 cents. In the year-ago quarter, the company had recorded earnings per share (EPS) of 62 cents, driven …

Bittium Oyj (HLSE:BITTI) Earnings Reset The Valuation Debate

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. How Bittium Oyj's Latest Earnings Shape the Investment Picture Bittium Oyj (HLSE:BITTI) reported half …

Die Boston Scientific Corporation (NYSE:BSX) hat soeben ihre Ergebnisse veröffentlicht, und Analysten haben ein Kursziel von 62,69 US-Dollar festgelegt.

Koninklijke Philips NV (PHG) Aktuelle Aktien-News

IDEXX Laboratories Inc (IDXX) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

Boston Scientific Corp (BSX) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

Eckert & Ziegler SE: Konsensus der Analysten und Kursziel | 565970 | DE0005659700

Clinical Visits Keep Falling. IDEXX Laboratories’ Q2 Earnings Report Say That Doesn’t Matter.

Warum die Pfizer-Aktie (PFE) trotz eines Nettoverlusts im zweiten Quartal um 5,2 % gestiegen ist, nachdem das Unternehmen seine Prognose für 2026 angehoben hat

Fresenius Medical Care AG: Ergebnis verfehlt Analystenschätzungen: Das prognostizieren Analysten jetzt

Werden die neue EXENT-Myelom-Plattform von Thermo Fisher (TMO) und die Ergebnisse des zweiten Quartals die Einschätzung des Unternehmens im Diagnostikbereich verändern?

Merck KGaA hebt nach starkem Q2 die Prognose für 2026 an

Fresenius Medical Care (FMC) St-Aktie: DZ BANK vergibt Bewertung mit Kaufen

Zoetis Inc. passt Gewinnprognose für das Gesamtjahr 2026 an

Merck KGaA gibt Ergebnisprognose für das Jahr 2026 ab

Becton Dickinson Aktie steigt nach überzeugenden Quartalszahlen und angehobener Prognose

Becton, Dickinson: Bereinigter Gewinn und Umsatz im dritten Geschäftsquartal steigen; Prognose für bereinigtes EPS 2026 angehoben

Becton Dickinson übertrifft Erwartungen und hebt Prognose an

Sanofi Aktie: 33,3 Prozent EPS-Wachstum im Q2

Unitedhealth Group Inc (UNH) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

Johnson & Johnson (JNJ) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen